Á lódáil...
Severe hemorrhagic colitis in a patient with chronic myeloid leukemia in the blastic phase after dasatinib use
Dasatinib is a second-line tyrosine kinase inhibitor used in patients with imatinib resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute leukemia. Gastrointestinal bleeding may occur in up to 7% of patients using dasatinib, although, severe dasatinib-rela...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Baishideng Publishing Group Co., Limited
2013
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3740261/ https://ncbi.nlm.nih.gov/pubmed/23946889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4291/wjgp.v4.i3.59 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|